NEJM Journal Watch - General Medicine

A single-center study suggests they are.

Consensus recommendations span diagnosis, risk assessment, evaluation, and management of obesity.

Use of this drug should be limited to treating infections with organisms that are resistant to first-line agents.

Randomized trials of not-yet-approved agents highlight once-monthly injection, a new oral option, and drug combination.

Dr. Paul Sax shares 20 (mostly related to infectious disease) things he's found interesting lately in HIV and ID Observations.

Risk for cefepime-induced neurotoxicity was elevated in patients receiving CAR T-cell therapy.

PREVENT proved much more accurate than the older calculator in older adults.

In this meta-analysis, about 1 in 10 first-degree relatives had celiac disease.

Dr. Paul Sax wonders if learning objectives are actually an essential part of effective teaching in HIV and ID Observations.

NSAIDs were associated with more adverse CV events than was colchicine.